Vacuum-assisted Conservative Treatment for the Management and Salvage of Exposed Prosthetic Hemodialysis Access

Vacuum-assisted Conservative Treatment for the Management and Salvage of Exposed Prosthetic Hemodialysis Access

Eur J Vasc Endovasc Surg 28, 397–399 (2004) doi: 10.1016/j.ejvs.2004.05.011, available online at http://www.sciencedirect.com on SHORT REPORT Vacuum...

158KB Sizes 0 Downloads 10 Views

Eur J Vasc Endovasc Surg 28, 397–399 (2004) doi: 10.1016/j.ejvs.2004.05.011, available online at http://www.sciencedirect.com on

SHORT REPORT

Vacuum-assisted Conservative Treatment for the Management and Salvage of Exposed Prosthetic Hemodialysis Access C. Vallet,1* F. Saucy,1 C. Haller,1 P. Meier,2 W. Rafoul3 and J.-M. Corpataux1 Departments of 1Thoracic and Vascular Surgery, 2Nephrology, and 3Plastic and Reconstructive Surgery, University Hospital, Lausanne, Switzerland Recurrent puncture of dialysis grafts can cause erosion and ulcer formation in the skin over the prosthetic material. Contamination of the wound can lead to infection of the graft, and the necessity to remove it. We describe four cases where agressive treatment with debridement, intravenous antibiotics and negative pressure therapy allowed prosthesis salvage without discontinuation of hemodialysis. Key Words: Areriovenous fistulae; End stage renal disease; Hemodialysis; Infection; Vacuum-assisted therapy.

Introduction Several complications associated with expanded polytetrafluoroethylene (ePTFE) graft placement for hemodialysis vascular access has been described. The leading cause of patient morbidity as well as access failure is infection.1,2 Recurrent puncture of dialysis grafts may cause erosion and ulcer formation in the skin over the prosthetic material.2 Contamination of the wound can lead to infection of the graft and the necessity to remove it surgically.3 A vacuum-assisted closure device (VAC) is used for the management of complicated wounds; it is associated with accelerated development of granulation tissue, earlier reepithelialization of wounds and decreased wound bacterial counts.4,5 To allow salvage of ePTFE grafts we used a vacuum dressing combined with intravenous antibiotics after debridement of the wound in four cases.

Short Report Four cases of wound dehiscence over ePTFE grafts for *Corresponding author. Dr Ce´dric Vallet, Department of Surgery, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, CH1011 Lausanne, Switzerland.

hemodialysis access presented between September and November 2002. There were three men and one woman, and the median age was 66.2 years old. Treatment consisted of debridement of the wound and application of a vacuum dressing, combined with intravenous antibiotics, after blood cultures and a swab of the wound were taken for microbiological examination. VAC consisted of placing a dressing sponge made of open-cell polyurethane ether foam onto the wound. Embedded in this sponge was a noncollapsible, sideported evacuation tube connected to an adjustable vacuum pump. A plastic adhesive drape was placed over the sponge to obtain an airtight seal. The vacuum pressure was adjustable up to 2 125 mmHg and was used intermittently. Dressings were removed every 3 –4 days. The pump, we used was a portable small pump designed for ambulatory treatment (KCI, San Antonio, TX, USA). Patients 1 and 2 developed wound dehiscence over the graft after repeated skin puncture (Fig. 1). Patient 3 had a wound dehiscence following surgery after a small infected haematoma was evacuated over the alloplastic material. Patient 4 developed a voluminous haematoma at the anterior aspect of the elbow after puncture. Blood cultures taken at the time of admission were sterile in all cases. Both haematomas were infected with Staphylococcus aureus and Staphylococcus

1078–5884/040397 + 03 $35.00/0 q 2004 Elsevier Ltd. All rights reserved.

398

C. Vallet et al.

Fig. 1. Close view of the wound dehiscence over prosthetic material.

epidermidis, respectively. Antibiotics were stopped if the culture were sterile and maintained for a total of 15 days if pathology was identified. Retraction of the wound over the ePTFE graft was obtained in patients 1– 3 with development of granulation tissue on two thirds of the graft’s circumference. Coverage of the alloplastic material was obtained by a local skin flap done under local anaesthesia (Fig. 2). For patient 4, coverage was obtained after direct closure under general anaesthesia. Wounds have been stable from 7 to 9 months. During all the treatment hemodialysis

Fig. 2. Result after local skin flap. Eur J Vasc Endovasc Surg Vol 28, October 2004

was continued using the same vascular access. Subatmospheric suction did not impair AVF outflow.

Discussion Infection accounts for about 20% of all vascular access complications.2 Native primary AVF have the lowest rate of infectious complications. Permanent duallumen venous catheters and ePTFE grafts have a much higher complication rate. Poor healing after

Vacuum Therapy for Exposed AVF

graft placement can cause erosion of the overlying skin with exposure and contamination of the graft. Haematomas can occasionally form around anastomosis sites and as well as seromas can act as infectious niduses developing into perigraft abscesses. Most of all, repeated needle puncture is the most common cause of infection.2 These mechanical injuries might result in ulcer formation overlying the access, which can become secondarily infected. If left untreated, infection can propagate to the subcutaneous tunnel surrounding the ePTFE graft and it becomes necessary to remove it surgically.3 VAC therapy has been reported to be useful in the treatment of wound infections by decreasing the wound bacterial counts and accelerating granulation tissue development.4,5 We demonstrated in four cases that graft salvage could be obtained with aggressive local care, vacuumassisted therapy and systemic antibiotics. These

399

preliminary results suggest that a randomised clinical trial comparing healing with or without vacuumassisted therapy should be carried out.

References 1 Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7(4):523–535. 2 Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60(1):1–13. 3 Gifford R. Management of tunnel infections and dialysis polytetrafluoroethylene grafts. J Vasc Surg 1985; 2:854– 858. 4 Demaria R, Giovannini U, Teot L. Using VAC to treat vascular bypass site infection. J Wound Care 2001; 10:12–13. 5 Joseph E. A prospective randomized trial of vacuum-assisted closure versus standard therapy of chronic nonhealing wounds. Wounds 2000; 12(3):60– 67. Accepted 25 May 2004 Available online 3 July 2004

Eur J Vasc Endovasc Surg Vol 28, October 2004